

HY-P99430 · 1 mg
MedChemExpress · Cat: HY-P99430
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/alnuctamab.html
Description
Alnuctamab EM901 is a bispecific T-cell engager targeting BCMA and CD3, belonging to an asymmetric two-armed humanized IgG1 antibody. Alnuctamab can simultaneously bind to BCMA expressed on the surface of myeloma cells and CD3 molecules on the surface of T cells, recruiting T cells to kill tumors. Alnuctamab is used for the research of multiple myeloma. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control HY-P99001 .







